David B. Fischer - 03 Dec 2025 Form 4 Insider Report for BALCHEM CORP (BCPC)

Role
Director
Signature
/s/ Travis Larsen, Attorney in Fact for David B Fischer
Issuer symbol
BCPC
Transactions as of
03 Dec 2025
Transactions value $
-$759,414
Form type
4
Filing time
05 Dec 2025, 16:28:08 UTC
Previous filing
02 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Fischer David B Director C/O BALCHEM CORPORATION, 5 PARAGON DRIVE, MONTVALE /s/ Travis Larsen, Attorney in Fact for David B Fischer 05 Dec 2025 0001305182

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCPC Common Stock Options Exercise $252K +3.38K +33.87% $74.57 13.4K 03 Dec 2025 Direct F1
transaction BCPC Common Stock Options Exercise $220K +2.62K +19.57% $84.09 16K 03 Dec 2025 Direct F1
transaction BCPC Common Stock Sale -$923K -6K -37.53% $153.91 9.99K 03 Dec 2025 Direct F2
transaction BCPC Common Stock Sale -$308K -2K -20.02% $154.15 7.99K 03 Dec 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCPC Stock Options Options Exercise $0 -3.38K -100% $0.00 0 03 Dec 2025 Common Stock 3.38K $74.57 Direct F4
transaction BCPC Stock Options Options Exercise $0 -2.62K -100% $0.00 0 03 Dec 2025 Common Stock 2.62K $84.09 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercise of fully vested non-qualified stock options.
F2 This transaction was executed in multiple sales ranging from $153.5100 to $154.2400 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
F3 This transaction was executed in multiple sales ranging from $153.9045 to $154.3400 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote.
F4 Stock options that vested 20% on February 15, 2019, 40% on February 15, 2020, and 40% on February 15, 2021, and are exercisable.
F5 Stock options that vested 20% on February 13, 2020, 40% on February 13, 2021, and 40% on February 13, 2022, and are exercisable.